Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (91-100 of 548) with videos related to

Pageof 55
Sort By:
British Journal of Pharmacology|July 1, 1979
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pigD Chadwick, P Jenner, C D Marsden
Neuroscience Letters|June 4, 1985
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetM Nomoto, P Jenner, C D Marsden
British Journal of Pharmacology|April 1, 2000
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primatesS A Treseder, M Jackson, P Jenner
British Journal of Pharmacology|June 1, 1975
Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsP Jenner, C D Marsden, E Peringer
Pharmacology, Biochemistry, and Behavior|October 1, 1976
Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activityA Dolphin, P Jenner, C D Marsden
Neuroreport|July 31, 1995
Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's diseaseJ P Spencer, P Jenner, B Halliwell
Biochemical Pharmacology|March 1, 1983
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathwaysC Reavill, P Jenner, C D Marsden
Biochemical Pharmacology|June 15, 1983
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigsG Luscombe, P Jenner, C D Marsden
Neuroscience Letters|November 11, 1988
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmosetM Nomoto, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|September 1, 1978
3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the ratA Dolphin, P Jenner, C D Marsden
Pageof 55

Showing results (91-100 of 548) with videos related to

Sort By:
Pageof 55
British Journal of Pharmacology|July 1, 1979
5-Hydroxytryptamine and myoclonus induced by 1,2-di-hydroxybenzene (catechol) in the guinea-pigD Chadwick, P Jenner, C D Marsden
Neuroscience Letters|June 4, 1985
The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmosetM Nomoto, P Jenner, C D Marsden
British Journal of Pharmacology|April 1, 2000
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primatesS A Treseder, M Jackson, P Jenner
British Journal of Pharmacology|June 1, 1975
Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodentsP Jenner, C D Marsden, E Peringer
Pharmacology, Biochemistry, and Behavior|October 1, 1976
Noradrenaline synthesis from L-DOPA in rodents and its relationship to motor activityA Dolphin, P Jenner, C D Marsden
Neuroreport|July 31, 1995
Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's diseaseJ P Spencer, P Jenner, B Halliwell
Biochemical Pharmacology|March 1, 1983
Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathwaysC Reavill, P Jenner, C D Marsden
Biochemical Pharmacology|June 15, 1983
Alterations in brain 5HT and tryptamine content during indoleamine-induced myoclonus in guinea pigsG Luscombe, P Jenner, C D Marsden
Neuroscience Letters|November 11, 1988
The D1 agonist SKF 38393 inhibits the antiparkinsonian activity of the D2 agonist LY 171555 in the MPTP-treated marmosetM Nomoto, P Jenner, C D Marsden
The Journal of Pharmacy and Pharmacology|September 1, 1978
3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the ratA Dolphin, P Jenner, C D Marsden
Pageof 55